Important Information
If you are interested in applying for this study, please:
- read the study description and study information document
- review the Visit Planner dates in your location and confirm that you are available for the stated dates.
- If you have not yet registered with us, click on the ‘Register’ button at the top of this page and answer the questions.
- If you have already registered with us, answer the pre-screening questions listed below and submit your interest.
We will then contact you to check your suitability.
Study Information
New Zealand Clinical Research is trialling an investigational medicine that could help people with psoriasis.
Psoriasis is a long term condition where the immune system causes the skin to produce too many cells leading to red, scaly patches. It can cause a substantial impact on quality of life.
It is a condition in which skin cells build up and form scales and itchy, dry patches. Triggers can include infections, stress and cold. Currently, psoriasis may be difficult to treat and there is currently no cure, and no single treatment works for everyone.
The investigational medicine, ORKA-002, may help people with psoriasis by reducing inflammatory signaling in the immune system to alleviate psoriasis symptoms such as red patches of skin and silvery scales to improve overall quality of life for people affected with this condition.
This is an investigational drug because it has not been approved by MedSafe or other drug regulatory authorities.
Study Candidates
Healthy Males and Females
- Aged between 18 – 65 years
- Have a BMI (Body Mass Index) between 18 – 32 kg/m2
- Not currently taking any regular prescription medications
- Smokers/Vapers (less than 5 per day) allowed
What is Involved?
Study Visits: 4-night stay + 13 clinic visits
Reimbursement: Up to $14,000 before tax